ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

AACI Asks NCI for Better Definitions Of Center Types, Development Of Objectives, Priorities

June 25, 1976

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

PCI Files Application For Research Base COP

September 9, 1994

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012